Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Abdominal Neoplasms

3,4-methylenedioxyamphetamine has been researched along with Abdominal Neoplasms in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Abdominal Neoplasms: New abnormal growth of tissue in the ABDOMEN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eaves, SL1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Abdominal Neoplasms

ArticleYear
Permission to leave.
    The American journal of nursing, 1996, Volume: 96, Issue:3

    Topics: Abdominal Neoplasms; Attitude to Death; Female; Humans; Love; Male; Marriage; Right to Die

1996